Uncommon localization of amyloidosis in gallbladder: Description of a case and brief literature review
Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 2
Abstract
Amyloidosis is a rare disease that is caused by extracellular deposits of amorphous, insoluble fibrillar protein, which often occur in the kidneys, the heart, the nervous system, the digestive tract, especially the hepatosplenic and intestinal tract, and can be present in bone marrow, though unusual in the gallbladder. The interest of this case lies in the rarity of amyloidosis localisation and in the uncommon clinical presentation as acute cholecystitis. We have reviewed cases of amyloidosis with gallbladder involvement in literature and briefly discussed thepredictive value of the main histological diagnostic methods.
Authors and Affiliations
Daniela Tirotta, Vittorio Durante
Keywords
Related Articles
- EP ID EP78031
- DOI -
- Views 146
- Downloads 0
Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats
This study examined the possible hepatoprotective effect of aminoguanidine in comparison with silymarin and investigated the possible beneficial effects of the combination of aminoguanidine and silymarin on CCL4-induced...
Poor response to hepatitis C treatment in elderly patients
[b]Introduction[/b]. Treatment of genotype 1 chronic hepatitis C in elderly patients has been associated with low rates of a sustained virological response (SVR), but the reasons are unclear. Objective. To determine the...
Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg status
Serum hepatitis B virus (HBV) DNA level is a predictor of the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients. Nevertheless, the distribution of viral load levels in chronic HBV pati...
Detection of hepatitis B activity in HBeAg-negative carriers with normal aminotransferase levels in central Brazil
Background and rationale for the study. Hepatitis B virus (HBV) chronic infection may follow a benigncourse with low risk of cirrhosis or liver cancer. As differentiation of inactive status from HBeAg-negative chronic he...
Chronic hepatitis C successfully treated with telaprevir, pegylated interferon and ribavirin in severe aplastic anemia